NovalGen

Breakthrough multi-specific antibody therapies

About

Immuno-oncology company developing bispecific therapies

5 technologies & apps tracked

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.